US OptionsDetailed Quotes
RIGL241220C6000
- 4.00
- 0.000.00%
15min DelayClose Dec 13 16:00 ET
0.00High0.00Low
4.00Open4.00Pre Close0 Volume1 Open Interest6.00Strike Price0.00Turnover611.38%IV-47.12%PremiumDec 20, 2024Expiry Date12.91Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9781Delta0.0040Gamma1.45Leverage Ratio-0.0667Theta0.0007Rho1.42Eff Leverage0.0011Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet